1-methyl-2-pyrrolidone (NMP) manufactured, placed on the market or used as a substance on its own or in mixtures in a concentration equal to or greater than 0,3%.

Draft Commission Regulation amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards 1-methyl-2-pyrrolidone (and its accompanying Annex) (4 pages + Annex 2 pages, in English)

This draft Regulation relates to a new entry in Annex XVII to Regulation (EC) No 1907/2006.

It would prohibit the placing on the market of 1-methyl-2-pyrrolidone (NMP) unless:

•  the registration dossiers are updated with the new Derived No Effect Levels (DNELs) for inhalation and dermal exposure indicated in the proposal, which effectively set occupational exposure limits, and

•  manufacturers and downstream users comply with those values in the workplace.

A general deferral of application of the restriction of 2 years is proposed to allow stakeholders to take the necessary compliance measures. For the wire-coating industry, which would need to replace part of its older production lines prematurely to comply with the new DNELs, a longer specific deferral of 6 years is proposed.